Search Results for: ALCL

Adcetris (Brentuximab Vedotin)

Adcetris (brentuximab vedotin, SGN-35) is an approved therapy for classical Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (sALCL) developed through collaboration between Millenium Pharmaceuticals (part of Takeda ... Read more